ClinicalTrials.gov
public full text
Public Domain
Trial of Enteral Glutamine on Intestinal Permeability in Critically Ill Patients
Glutamine-induced recovery in intestinal barrier function by reducing bacterial translocation was demonstrated in previous studies. In this trial, intensive care unit patients with enteral feeding will receive either enteral glutamine or maltodextrin as placebo for 10 days and the effects of the intervention on intestinal permeability will be assessed.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Gastrointestinal Dysfunction During Enteral Nutrition in Critically Ill Patients#917153
- Use of Ketamine Associate With an Opioid for Sedation in ICU#1369458
- The frequency, risk factors, and complications of gastrointestinal dysfunction during enteral nutrition in critically ill patients#955303
- The Use of Ketamine and Dexmedetomidine in Intensive Care Sedation#1046013
- Single Dose Enteral Tranexamic Acid in Critically Ill Patients#1384256
Record · ID 1474541
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive